Skip to content

A Systemic Screening for TB Disease in High-risk Groups in Barcelona

Implementing a Systemic Screening for TB Disease in High-risk Groups in Barcelona Area

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06706596
Acronym
SYS-TB-S
Enrollment
3000
Registered
2024-11-26
Start date
2022-07-22
Completion date
2026-12-31
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis, Tuberculosis, Pulmonary

Keywords

Tuberculosis, Tuberculosis infection, Tuberculosis screening, Vulnerable populations, Refugees, Migrants, Pulmonary tuberculosis

Brief summary

The purpose of this screening study is to identify and screen vulnerable population in Barcelona for active pulmonary tuberculosis

Detailed description

If eligible and verbal consent is obtained, individuals: 1. Will attend a small talk/lecture about Tuberculosis (TB) disease 2. Will be interviewed and screened for the presence of TB symptoms: cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks 3. Individuals screened positive for TB will be referred to the hospital for further testing (Chest X-ray, visit, lab tests)

Interventions

OTHERScreening for TB symptoms

Individuals will be screened for cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks

DIAGNOSTIC_TESTChest X-ray

Chest X-ray will be performed to diagnose or exclude TB

Sponsors

Catalan Public Health Agency
CollaboratorUNKNOWN
Consorci Sanitari de Barcelona (CSB)
CollaboratorUNKNOWN
SMA-TB Consortium
CollaboratorUNKNOWN
INNOVA4TB Consortium
CollaboratorUNKNOWN
Fundació Lluita contra les Infeccions
CollaboratorUNKNOWN
Hospital Vall d'Hebron -Unitat de Drassanes
CollaboratorUNKNOWN
ADVANCE-TB Consortium
CollaboratorUNKNOWN
Germans Trias i Pujol Hospital
CollaboratorOTHER
Fundació Institut Germans Trias i Pujol
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

-Belonging to a population at high risk for tuberculosis (TB)

Exclusion criteria

-Not belonging to a population at high risk for tuberculosis (TB)

Design outcomes

Primary

MeasureTime frameDescription
Number of individuals who screen positive for pulmonary TB symptoms1 dayNumber of individuals who screen positive for pulmonary TB symptoms (cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks)
Number of individuals who are diagnosed with pulmonary TB symptoms1 monthNumber of individuals who are diagnosed with pulmonary TB symptoms after referral to the hospital

Secondary

MeasureTime frameDescription
Cost-effectiveness analysis1 dayCost-effectiveness analysis of the TB screening
Time spent during screening1 dayDuration of each step of the screening will be analysed: duration of talk about TB, duration of waiting time before individual gets screened, duration of screening

Countries

Spain

Contacts

Primary ContactCristina Vilaplana, MD, PhD
cvilaplana@igtp.cat+34930330527
Backup ContactNino Gogichadze, MD, MsC
ngogichadze@igtp.cat+34661079125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026